Co-Authors
This is a "connection" page, showing publications co-authored by Sven Saussez and Carlos Chiesa-Estomba.
Connection Strength
9.063
-
Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol. 2020 11; 27(11):2318-2321.
Score: 0.896
-
Patterns of Gustatory Recovery in Patients Affected by the COVID-19 Outbreak. Virol Sin. 2020 12; 35(6):833-837.
Score: 0.896
-
Olfactory and gustatory dysfunctions in COVID-19. First reports of Latin-American ethnic patients. Am J Otolaryngol. 2020 Sep - Oct; 41(5):102605.
Score: 0.886
-
[The alteration of smell and taste in COVID-19 patients. A diagnostic resource in primary care]. Aten Primaria. 2020 10; 52(8):592-593.
Score: 0.884
-
Correction to: Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2861.
Score: 0.240
-
Psychophysical evaluations are important, usefulness and usability approaches to study the smell disorder related to COVID-19. J Intern Med. 2021 08; 290(2):468-469.
Score: 0.238
-
Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study. Pathogens. 2021 Jun 04; 10(6).
Score: 0.237
-
Clinical features of patients who had two COVID-19 episodes: a European multicentre case series. J Intern Med. 2021 Aug; 290(2):421-429.
Score: 0.233
-
Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19. J Intern Med. 2021 08; 290(2):464-465.
Score: 0.232
-
Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2851-2859.
Score: 0.231
-
Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med. 2021 Aug; 290(2):451-461.
Score: 0.231
-
Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain. Med Clin (Engl Ed). 2021 Jan 22; 156(2):61-64.
Score: 0.230
-
Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Front Med (Lausanne). 2020; 7:582802.
Score: 0.229
-
[Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain]. Med Clin (Barc). 2021 01 22; 156(2):61-64.
Score: 0.226
-
ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review. Head Neck Pathol. 2021 Mar; 15(1):225-235.
Score: 0.225
-
Clinical and Radiological Evaluations of COVID-19 Patients With Anosmia: Preliminary Report. Laryngoscope. 2020 11; 130(11):2526-2531.
Score: 0.224
-
Objective Olfactory Findings in Hospitalized Severe COVID-19 Patients. Pathogens. 2020 Jul 31; 9(8).
Score: 0.224
-
In Reference to Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020 09; 130(9):E504-E505.
Score: 0.222
-
Gustatory dysfunctions in COVID-19. Eur Arch Otorhinolaryngol. 2020 08; 277(8):2397-2398.
Score: 0.222
-
Systematic review of international guidelines for tracheostomy in COVID-19 patients. Oral Oncol. 2020 09; 108:104844.
Score: 0.221
-
Features of Mild-to-Moderate COVID-19 Patients With Dysphonia. J Voice. 2020 Jun 04.
Score: 0.221
-
Patient-Reported Outcome Questionnaires for the evaluation of olfactory and gustatory dysfunctions in COVID-19. Eur Arch Otorhinolaryngol. 2020 08; 277(8):2393-2394.
Score: 0.221
-
Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study. Ear Nose Throat J. 2020 Nov; 99(9):579-583.
Score: 0.221
-
Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19. Ann Intern Med. 2020 10 20; 173(8):672-675.
Score: 0.221
-
Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck. 2020 Jul; 42(7):1583-1590.
Score: 0.221
-
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug; 277(8):2251-2261.
Score: 0.219
-
Correction to: Sinus and anterior skull base surgery during the COVID-19 pandemic: systematic review, synthesis and YO-IFOS position. Eur Arch Otorhinolaryngol. 2021 Jul; 278(7):2661.
Score: 0.060
-
Validity and reliability of the COVID-19 symptom index, an instrument evaluating severity of general and otolaryngological symptoms. Acta Otolaryngol. 2021 Jun; 141(6):615-620.
Score: 0.058
-
Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients. Rhinology. 2021 Feb 01; 59(1):21-25.
Score: 0.058
-
COVID-19 Reinfection and Second Episodes of Olfactory and Gustatory Dysfunctions: Report of First Cases. Ear Nose Throat J. 2020 Nov 10; 145561320970105.
Score: 0.057
-
Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020 Aug; 134(8):703-709.
Score: 0.056
-
A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study. J Med Virol. 2021 02; 93(2):983-994.
Score: 0.056
-
Sinus and anterior skull base surgery during the COVID-19 pandemic: systematic review, synthesis and YO-IFOS position. Eur Arch Otorhinolaryngol. 2021 Jun; 278(6):1733-1742.
Score: 0.056
-
Ethyl alcohol threshold test: a fast, reliable and affordable olfactory Assessment tool for COVID-19 patients. Eur Arch Otorhinolaryngol. 2020 Oct; 277(10):2783-2792.
Score: 0.056
-
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020 09; 288(3):335-344.
Score: 0.055